Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.677
-0.003 (-0.15%)
At close: Mar 19, 2026
HRGN Market Cap
HRGN has a market cap or net worth of $29.49 million as of March 24, 2026. Its market cap has decreased by -17.88% in one year.
Market Cap
29.49M
Enterprise Value
28.34M
Revenue
704.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.68
Market Cap Chart
Since October 21, 2013, HRGN's market cap has decreased from 48.00M to 29.49M, a decrease of -38.56%. That is a compound annual growth rate of -3.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 29.49M | -6.65% |
| Dec 31, 2025 | 31.59M | -33.41% |
| Dec 30, 2024 | 47.44M | -31.84% |
| Dec 29, 2023 | 69.60M | 3.94% |
| Dec 30, 2022 | 66.96M | 170.54% |
| Dec 31, 2021 | 24.75M | 110.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicapsys Life Sciences | 48.56M |
| Anebulo Pharmaceuticals | 41.60M |
| Cell Source | 37.29M |
| ZIVO Bioscience | 33.01M |
| Arch Biopartners | 28.95M |
| Provectus Biopharmaceuticals | 21.41M |
| NKGen Biotech | 20.90M |
| Zenith Capital | 20.77M |